VALYSTR · Stock research
Listed on NasdaqGM. What the market is pricing into Cronos Group Inc. (CRON) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Drug Manufacturers - Specialty & Generic · market value about $1.2B · P/E 18.4 · revenue $179M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows